Author:
Bussone Guillaume,Hachulla Eric,Sibilia Jean,Michel Marc,Godeau Bertrand,Guillevin Loïc,Mouthon Luc
Reference94 articles.
1. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis;Edwards;The New England journal of medicine,2004
2. The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial;Emery;Arthritis and rheumatism,2006
3. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy. Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks;Cohen;Arthritis and rheumatism,2006
4. The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura;Cooper;British journal of haematology,2004
5. An open study of B lymphocyte depletion in systemic lupus erythematosus;Leandro;Arthritis and rheumatism,2002
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献